Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease

NCT03476317 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Crohn Disease

Interventions

DRUG: Vancomycin
DRUG: Neomycin
DRUG: Ciprofloxacin
DRUG: Polyethylene Glycol 3350
DRUG: Fluconazole

Sponsor

Children's Hospital of Philadelphia

Collaborators

[object Object]
[object Object]